| Daniel Abraha, MD | |
|
7950 W Jefferson Blvd, Suite 210, Fort Wayne, IN 46804-4140 | |
| (260) 435-7355 | |
| (260) 435-7637 |
| Full Name | Daniel Abraha |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Critical Care Medicine |
| Location | 7950 W Jefferson Blvd, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063419166 | NPI | - | NPPES |
| 200816520 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0203X | Pediatrics - Pediatric Critical Care Medicine | 01061925A (Indiana) | Primary |
| Entity Name | Lutheran Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164662805 PECOS PAC ID: 4981751617 Enrollment ID: O20090414000705 |
News Archive
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
Every 40 seconds someone in the United States has a stroke. Stroke is the fourth leading cause of death and the number one cause of adult disability in the country. While stroke often occurs without warning, understanding risk factors and learning to recognize symptoms can potentially save lives and limit damage if a stroke occurs. In recognition of National Stroke Awareness Month, Northwestern Medicine experts encourage consumers learn about their potential risk factors and start making lifestyle decisions that may decrease their likelihood of having a stroke.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.
Researchers at Washington University School of Medicine in St. Louis and King's College London have independently identified DNA on chromosome 3 that appears to be related to depression.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Abraha, MD 6920 Pointe Inverness Way Ste 200, Fort Wayne, IN 46804-7934 Ph: (260) 479-3516 | Daniel Abraha, MD 7950 W Jefferson Blvd, Suite 210, Fort Wayne, IN 46804-4140 Ph: (260) 435-7355 |
News Archive
Breast imaging reports generated using an automatic speech recognition system are nearly six times more likely to contain major errors than those generated with conventional dictation transcription, a new study in Canada shows.
Every 40 seconds someone in the United States has a stroke. Stroke is the fourth leading cause of death and the number one cause of adult disability in the country. While stroke often occurs without warning, understanding risk factors and learning to recognize symptoms can potentially save lives and limit damage if a stroke occurs. In recognition of National Stroke Awareness Month, Northwestern Medicine experts encourage consumers learn about their potential risk factors and start making lifestyle decisions that may decrease their likelihood of having a stroke.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has been accepted for formal review.
Researchers at Washington University School of Medicine in St. Louis and King's College London have independently identified DNA on chromosome 3 that appears to be related to depression.
› Verified 7 days ago
Dr. Melissa S Rice, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 11115 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-672-6443 Fax: 260-672-6459 | |
Vaneska Bottino Da Costa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 Fax: 260-435-9763 | |
Ronald R Hall, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1717 S Calhoun St, Fort Wayne, IN 46802 Phone: 260-458-2641 Fax: 260-969-0007 | |
Mrs. Lindsay M Ligler, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2810 Dupont Commerce Ct, Fort Wayne, IN 46825 Phone: 260-490-7337 | |
Osita Victor Ezeakudo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2510 E Dupont Rd, Suite 200, Fort Wayne, IN 46825 Phone: 260-432-4913 Fax: 260-969-6832 | |
Dr. Michael Philip Dick, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3898 New Vision Dr, Fort Wayne, IN 46845 Phone: 260-425-5750 Fax: 260-425-5755 | |
Pamela Thomas, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7950 W Jefferson Blvd, Suite 210, Fort Wayne, IN 46804 Phone: 260-432-2297 Fax: 260-434-6420 |